The Role of the OSM/OSMRβ Axis in Chronic Liver Disease Progression and Hepatocellular Carcinoma Development: A Focus on MASLD/MASH
Beatrice Foglia, Jessica Nurcis, Marta Signorini, Erica Novo, Claudia Bocca, Stefania Cannito, Maurizio Parola · 2026
Read The Role of the OSM/OSMRβ Axis in Chronic Liver Disease Progression and Hepatocellular Carcinoma Development: A Focus on MASLD/MASH by Beatrice Foglia, Jessica Nurcis, Marta Signorini, Erica Novo, Claudia Bocca, Stefania Cannito, Maurizio Parola (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13607418.txt.
Description
Beatrice Foglia leads a team that reviews a cytokine axis in liver disease. Their review from twenty twenty-six deals with oncostatin M and its receptor. Fatty liver disease is now a top cause of chronic liver ills.
Its spread tracks obesity and type two diabetes rates. Two drugs were lately approved for the condition. Their power to slow advance helps only some patients. No data yet cover cirrhosis or liver cancer outcomes. Marks to flag patients at risk are lacking. Swelling signals drive disease advance and cancer growth. Inflammation signals are central to that story.
Catalog record
| CREATOR | Beatrice Foglia, Jessica Nurcis, Marta Signorini, Erica Novo, Claudia Bocca, Stefania Cannito, Maurizio Parola |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 83 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |